# RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML

> **NCT01307241** · — · UNKNOWN · sponsor: **National Institute of Cancerología** · enrollment: 50 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia.
- Acute Myeloblastic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01307241
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01307241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01307241, "RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01307241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*